CRF Health Partners Innovative US Biotech with TrialMax eCOA Solution for Phase III Prostate Oncology Study Read more
PolyActiva Commences Its First Phase I Clinical Trial with Potential to Improve Daily Lives of Millions of Glaucoma Patients Read more
Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy Read more
Tolero Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial Read more
Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip Read more
Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer Read more
Inovio Announces First Patient Dosed in Trial to Determine PENNVAX-GP’s Ability to Induce Remission of HIV Infection Read more
Izana Bioscience Initiates Namilumab Phase II Proof-of-Concept Clinical Study in Ankylosing Spondylitis Read more